DT
HealthMore in Health→
Metformin’s Mechanism May Center on the Gut, Not the Liver
Key Takeaways
- Northwestern researchers report that metformin may act primarily in the gut rather than the liver.
- The mouse study found the drug slows mitochondrial energy production in intestinal cells, increasing glucose use there.
- The findings could redirect future diabetes drug development toward gut-targeted therapies.
DE
DT Editorial Team··via medicalxpress.com